Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.
D Turk, … , K S Nair, R Rizza
D Turk, … , K S Nair, R Rizza
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):755-762. https://doi.org/10.1172/JCI117723.
View: Text | PDF
Research Article

The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

  • Text
  • PDF
Abstract

The mechanism(s) of insulin resistance in non-insulin-dependent diabetes mellitus remains ill defined. The current studies sought to determine whether non-insulin-dependent diabetes mellitus is associated with (a) a delay in the rate of onset of insulin action, (b) impaired hepatic and extrahepatic kinetic responses to insulin, and (c) an alteration in the contribution of gluconeogenesis to hepatic glucose release. To answer these questions, glucose disappearance, glucose release, and the rate of incorporation of 14CO2 into glucose were measured during 0.5 and 1.0 mU/kg-1 per min-1 insulin infusions while glucose was clamped at approximately 95 mg/dl in diabetic and nondiabetic subjects. The absolute rate of disappearance was lower (P < 0.05) and the rate of increase slower (P < 0.05) in diabetic than nondiabetic subjects during both insulin infusions. In contrast, the rate of suppression of glucose release in response to a change in insulin did not differ in the diabetic and nondiabetic subjects during either the low (slope 30-240 min:0.02 +/- 0.01 vs 0.02 +/- 0.01) or high (0.02 +/- 0.00 vs 0.02 +/- 0.00) insulin infusions. However, the hepatic response to insulin was not entirely normal in the diabetic subjects. Both glucose release and the proportion of systemic glucose being derived from 14CO2 (an index of gluconeogenesis) was inappropriately high for the prevailing insulin concentration in the diabetic subjects. Thus non-insulin-dependent diabetes mellitus slows the rate-limiting step in insulin action in muscle but not liver and alters the relative contribution of gluconeogenesis and glycogenolysis to hepatic glucose release.

Authors

D Turk, A Alzaid, S Dinneen, K S Nair, R Rizza

×

Total citations by year

Year: 2017 2016 2015 2013 2011 2009 2008 2006 2005 2004 2003 2002 2001 2000 1999 1998 1996 1957 Total
Citations: 1 1 1 2 1 1 2 1 1 1 3 3 2 1 2 1 3 1 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
GC-MS-based Metabolomic Profiling of Thymoquinone in Streptozotocin-induced Diabetic Nephropathy in Rats
M Raish, A Ahmad, BL Jan, KM Alkharfy, K Mohsin, SR Ahamad, MA Ansari
Natural Product Communications 2017
Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply?
RA Rizza, G Toffolo, C Cobelli
Diabetes 2016
Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
E Tozzo, G Bhat, K Cheon, RC Camacho, H Ashida
PloS one 2015
The role of endothelial insulin signaling in the regulation of glucose metabolism
T Kubota, N Kubota, T Kadowaki
Reviews in Endocrine and Metabolic Disorders 2013
Use of dicarboxylic acids in type 2 diabetes: Dicarboxylic acids for type 2 diabetes
G Mingrone, L Castagneto-Gissey, K Macé
British Journal of Clinical Pharmacology 2013
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal
The Metabolic Syndrome 2011
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action
EJ Barrett, EM Eggleston, AC Inyard, H Wang, G Li, W Chai, Z Liu
Diabetologia 2009
Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content
B Ravikumar, J Gerrard, CD Man, MJ Firbank, A Lane, PT English, C Cobelli, R Taylor
Diabetes 2008
Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes
A Kotronen, L Juurinen, M Tiikkainen, S Vehkavaara, H Yki–Järvinen
Gastroenterology 2008
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance
DN Reeds, WT Cade, BW Patterson, WG Powderly, S Klein, KE Yarasheski
Diabetes 2006
The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function
HM Cherwinski, CA Murphy, BL Joyce, ME Bigler, YS Song, SM Zurawski, MM Moshrefi, DM Gorman, KL Miller, S Zhang, JD Sedgwick, JH Phillips
Journal of immunology (Baltimore, Md. : 1950) 2005
Assessment of Hepatic Glucose Metabolism by Indirect Calorimetry in Combination with a Non-Invasive Technique Using Naturally Enriched <sup>13</sup>C Glucose in Healthy Children and Adolescents
R Selz, FR Jornayvaz, L Tappy, V Woringer, GE Theintz
Hormone Research 2004
Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions
J Radziuk, S Pye
Best Practice & Research Clinical Endocrinology & Metabolism 2003
Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
P Staehr, K Hojlund, O Hother-Nielsen, JJ Holst, H Beck-Nielsen
Diabetic Medicine 2003
Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects
PE Carey, J Halliday, JE Snaar, PG Morris, R Taylor
American journal of physiology. Endocrinology and metabolism 2003
Hepatic glucose production: therapeutic target in type 2 diabetes?
P Staehr, O Hother-Nielsen, H Beck-Nielsen
Diabetes, Obesity and Metabolism 2002
Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes
P Halvatsiotis, KR Short, M Bigelow, KS Nair
Diabetes 2002
Regulation of endogenous glucose production after a mixed meal in type 2 diabetes
P Singhal, A Caumo, PE Carey, C Cobelli, R Taylor
American journal of physiology. Endocrinology and metabolism 2002
Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients
P Staehr, O Hother-Nielsen, K Levin, JJ Holst, H Beck-Nielsen
Diabetes 2001
Protein Metabolism in Clinically Stable Adult Cystic Fibrosis Patients With Abnormal Glucose Tolerance
A Moran, C Milla, R Ducret, KS Nair
Diabetes 2001
Reduced synthesis of muscle proteins in chronic renal failure
D Adey, R Kumar, JT McCarthy, KS Nair
American journal of physiology. Endocrinology and metabolism 2000
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron
Journal of Clinical Investigation 1999
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron
Diabetes 1999
Slower activation of insulin action in hypertension associated with obesity
G Biolo, G Toigo, B Ciocchi, R Situlin, G Guarnieri
Journal of Hypertension 1998
Insulin resistance in non-insulin-dependent diabetes mellitus
AA Alzaid
Acta Diabetologica 1996
The Lxl gene maps to mouse Chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters
N Schweifer, DP Barlow
Mammalian Genome 1996
Insulin resistance in non-insulin-dependent diabetes mellitus: A review
AA Alzaid
Acta Diabetologica 1996
Insulin Resistance
A Voll, J Kloster
Acta Medica Scandinavica 1957

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts